Aniruddha Ganguly Ph.D.

Program Director

Dr. Aniruddha Ganguly earned his Ph.D. in Cell Biology and trained in tumor biology. He has expertise in mechanisms of tumor development and metastasis, tumor microenvironment, tumor cell-macrophage interactions, biospecimen processing and banking, cancer biomarkers, clinical assay development, cancer diagnostics, molecular analysis technologies for cancer research, informatics technology for cancer research and cancer health disparities research. Before joining the National Cancer Institute (NCI) as a Program Director in 2011, Dr. Ganguly served as an Assistant Professor at Harvard Medical School/Harvard University for many years directing and conducting cancer biology research, and teaching MD/DMD students. During that time, his laboratory discovered a new protein-protein interaction between CEA and a 115 kDa monocyte/macrophage protein that has implications in colon tumorigenesis. He was supervisor of a CLIA certified IHC Clinical Services Laboratory of the department of Pathology at Massachusetts General Hospital, Boston. His research was funded by NIH R01, Corporate and Foundation grants. At the NCI, he has responsibilities for providing guidance to the planning, development, implementation, and evaluation of assigned biomedical research programs including, molecular diagnostic technologies, extracellular RNA/exosome/extracellular vesicles in cancer diagnosis research initiative, brain tumor research, NCI's brain tumor clinical trials, evaluation of Biomarker, Imaging and Quality of Life Studies Funding Program and core correlative science proposals. He organizes and hosts Cancer Diagnosis Program Science Session series. He has developed Program Project (P01) Development Guidance to support P01 investigators, particularly new investigators in their pre-application preparation stage. This guidance has been helping many investigators and NCI Program Directors to understand the process. He has published many scholarly articles including book chapters, presented extensively both nationally and internationally including as keynote speakers and chaired scientific sessions in conferences, a reviewer of many scientific journals and serves on journal editorial boards. He was scientific advisor of biotechnology/biopharmaceutical companies. He received many awards including University Gold-Medal for academic excellence from India, Bharat Gaurav (Pride of India) award (2010) from India, excellence in teaching awards (2007 & 2011) from Harvard Medical School, Partners in Excellence Award from Massachusetts General Hospital/Partners HealthCare (2009) for outstanding performance and commitment to excellence, Cancer Diagnosis Program Staff Award (2022 & 2024) for recognizable contributions to the program and NCI Director's Awards of Merit (2014 & 2015). He is founder and CEO of the American Association of Indian Scientists in Cancer Research (AAISCR, Inc.). He has a strong emphasis in mentoring and promoting young investigators involved in cancer research.